Pharma stocks advance as Trump rolls out drug-pricing deals with 9 more companies


The Trump administration on Friday announced deals with nine drugmakers aimed at lowering pharmaceutical prices, bringing its total number of drug-pricing agreements to 14.

You May Also Like

U.S. credit-card debt declines for second time in past three months, signaling plateau in borrowing

Consumer credit rose $8.9 billion in August, after surging a revised $26.6…

Argentina’s Milei backs away from dollarisation as central bank pick rejects role

The man named to lead Argentina’s central bank by libertarian president-elect Javier…

Social Security is on track to be insolvent in less than 10 years — but its commissioner says there’s ‘plenty of time’

The Old-Age and Survivors Insurance fund is expected to run out of…

Treasury yields hold steady on lack of market-moving catalysts

Yields on U.S. government debt edged slightly higher in Friday morning trading…